Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice
2007

Iodine-125 Seed Irradiation for Brain Tumors in Mice

Sample size: 21 publication Evidence: high

Author Information

Author(s): Verhoeff Joost JC, Stalpers Lukas JA, Coumou Annet W, Koedooder Kees, Lavini Cristina, Van Noorden Cornelis JF, Haveman Jaap, Vandertop William P, van Furth Wouter R

Primary Institution: Academic Medical Center, University of Amsterdam

Hypothesis

Can iodine-125 brachytherapy seeds improve survival in mice with brain tumors without causing fatal toxicity?

Conclusion

The use of iodine-125 brachytherapy seeds in mice with brain tumors significantly prolonged survival without fatal irradiation toxicity.

Supporting Evidence

  • In the sham group, 90% of mice showed lethal tumor progression within 6 weeks.
  • Only 18% of mice with the iodine-125 seed died from tumor progression within 13 weeks.
  • The median survival for sham seed mice was 4.6 weeks, while it was over 13 weeks for those with the iodine-125 seed.

Takeaway

Researchers used a special seed to treat brain tumors in mice, and it helped them live longer without getting sick from the treatment.

Methodology

Twenty-one nude mice had a guide-screw implanted in their skulls, followed by the injection of glioblastoma cells and implantation of iodine-125 seeds in some mice.

Limitations

The steep dose-rate gradient around the iodine-125 seed may lead to high dose inhomogeneity in the tumor.

Participant Demographics

Nude mice, 4-6 weeks of age.

Statistical Information

P-Value

0.0007

Statistical Significance

p < 0.0007

Digital Object Identifier (DOI)

10.1186/1748-717X-2-38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication